Malcolm Thaler, MD

One Medical provider Malcolm Thaler is based in New York. In addition to seeing patients, he is the acting clinical editor for the One Medical Blog. Malcolm enjoys being on the front lines of patient care, managing diagnostic and therapeutic challenges with a compassionate, integrative approach that stresses close doctor-patient collaboration. He is the author and chief editor of several best-selling medical textbooks and online resources, and has extensive expertise in managing a wide range of issues including the prevention and treatment of cardiovascular disease, diabetes, and sports injuries. Malcolm graduated magna cum laude from Amherst College, received his MD from Duke University, and completed his residency in Internal Medicine at Harvard's New England Deaconess Hospital and Temple University Hospital. He joined One Medical from his national award-winning Internal Medicine practice in Pennsylvania and was an attending physician at The Bryn Mawr Hospital since 1986. He is certified through the American Board of Internal Medicine. Malcolm sees patients in our Columbus Circle office in New York. Learn more about One Medical Group and our convenient locations in San Francisco, New York, DC, Boston, Chicago, and Los Angeles.

Has the Antibacterial Craze Gone Too Far?

We’ve become a nation of fanatical handwashers, hoping that regular scrubbing will protect us from viruses like colds and flus and harmful bacteria. Manufacturers worldwide have recognized a golden opportunity to exploit our germ-o-phobia, and have inundated the marketplace with not only antibacterial soaps,… read more >

New Guidelines for Treating High Blood Pressure

Nearly a third of the US population has high blood pressure, so the release of new guidelines on how doctors should treat high blood pressure (hypertension) is a very big deal, potentially affecting millions of people. The new guidelines announced by the Eighth Joint… read more >

The New Cholesterol Guidelines: The View from One Medical Group

The American College of Cardiology (ACC) and the American Heart Association (AHA) have issued a set of new guidelines for the use of cholesterol-lowering drugs simvastatin (Zocor), atorvastatin (Lipitor), rosuvastatin (Crestor), and others. These drugs are among our most important tools for preventing so-called… read more >

How to Lower Your Risk of Prostate Cancer

There are three three basic ways to theoretically lower the death rate from any particular cancer: 1. Prevention: decreasing one’s chances of getting the disease in the first place 2. Screening: detecting the cancer early while it’s still treatable and curable 3. Better treatment:… read more >

What You Need to Know About Ecstasy

This summer, numerous overdoses of the drug ecstasy were reported around the nation, including two highly publicized deaths that occurred over Labor Day weekend at a rave in New York City. Many users consider ecstasy a relatively safe recreational drug, and it has become… read more >

Should You Begin Screening Mammography Before 50?

The issue seemed to have been settled: According to the latest expert guidelines from the Centers for Disease Control (CDC) and the United States Preventive Services Task Force (USPSTF), women who do not have clear risk factors for breast cancer–such as a family history… read more >

New Concerns About Ambien

Ambien (generic name: zolpidem) is the most widely prescribed sleeping aid in the US. Although there are many very effective non-pharmacologic methods to treat insomnia, many of us still rely on the occasional Ambien to get to sleep when all else fails. Although there… read more >